This edition wraps up FY2025 M&A activity across Australian health, wellbeing and pharmaceuticals and sets out strategic perspectives for FY2026. It tracks listed-market performance, deal flow and strategic buyer activity across health, wellness, personal care and pharma.
Backed by Edison's cross-border deal experience and proprietary research, it helps founders and boards read valuation trends and position for the year ahead.
Read the full report
This report is available on request. Share a few details and we will send it to your inbox, then the download will start here.
More in Health, Wellbeing & Pharmaceuticals
Want early access to our next report?
Register your interest and we will share our latest sector insight as it is published.
Access the report
Tell us where to send it and the report will download right away. We will only use your details to share relevant Edison insight.
Thank you.
Your download should begin automatically. If it does not, use the button below.
Download the report ↓